NL-OMON42270已完成不适用
Bromocriptine and Insulin Sensitivity (the BIS study) - BIS study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Caucasian origin
- •- Subjects should be able and willing to give informed consent
- •- 18-35 years old
- •- BMI range of 19-23 kg/m2 or BMI> 27 kg/2
排除标准
- •- Renal failure (creatinine>135mmol/l)
- •- Liver failure (AST/ALT > 3 times higher than the normal upper value)
- •- Daily use of prescription medication and/or drugs
- •- Known hypersensitivity to bromocriptine.
- •- Uncontrolled hypertension
- •- Known history of coronary artery disease or valvulopathy
- •- History of severe psychiatric disorders.
- •- Prolactin-releasing pituitary tumor (prolactinoma).
研究者
相似试验
已完成
不适用
Bromocriptine and Insulin SensitivityInsulin SensitivityNCT02428946Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)15
Unknown
3 期
Effect of Bromocriptine on Insulin Resistance in Polycystic Ovarian Syndrome - A Pilot StudyPCOSInsulin ResistanceNCT02133755IWK Health Centre60
已完成
2 期
Effect of Bromocriptin in treatment of patients with polycystic ovaries.Polycystic Ovary Syndrome.Stein Leventhal SyndromeIRCT2013030412699N1Vice Chancellor for Development, Research and Technology of Ahvaz Jondishapour University of Medical44
已完成
2 期
Effect of bromocriptine in diabetes treatmentType 2 diabetes.Non-insulin-dependent diabetes mellitusIRCT201204156710N3Vice chancellor for research of Tabriz University of medical sciences60
已完成
4 期
QR-Bromocriptine as an Adjunct to Insulin and Metformin in the Treatment of Type 2 DiabetesDiabetes Mellitus, Type 2NCT01474018University of Texas Southwestern Medical Center15